Showing results (21-30 of 30) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 16, 2002
Selenium supplementation and lung cancer incidence: an update of the nutritional prevention of cancer trialMary E Reid, Anna J Duffield-Lillico, Linda Garland, et al.Biometrical Journal. Biometrische Zeitschrift|December 22, 2021
Robust group sequential designs for trials with survival endpoints and delayed responsePranab Ghosh, Robin Ristl, Franz König, et al.Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 8, 2017
Costs and Treatment Pathways for Type 2 Diabetes in the UK: A Mastermind Cohort StudyPeter Eibich, Amelia Green, Andrew T Hattersley, et al.Trials|July 14, 2025
Clinical trials with interim analyses: standardizing terminology to increase clarityElina Asikanius, Benjamin Hofner, Lisa V Hampson, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 9, 2002
Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer TrialAnna J Duffield-Lillico, Mary E Reid, Bruce W Turnbull, et al.BMJ Open|December 29, 2020
TriMaster: randomised double-blind crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as second-line or third-line therapy in patients with type 2 diabetes who have suboptimal glycaemic control on metformin treatment with or without a sulfonylurea-a MASTERMIND study protocolCatherine Angwin, Caroline Jenkinson, Angus Jones, et al.Nature Reviews. Drug Discovery|July 13, 2026
Design, simulate, refine: simulation-guided clinical trials for accelerated drug developmentElias Laurin Meyer, Tim Friede, Andrew P Grieve, et al.Journal of the National Cancer Institute|October 2, 2003
Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trialAnna J Duffield-Lillico, Elizabeth H Slate, Mary E Reid, et al.Medrxiv : the Preprint Server for Health Sciences|April 24, 2023
Type 2 Diabetes risk alleles in Peptidyl-glycine Alpha-amidating Monooxygenase influence GLP-1 levels and response to GLP-1 Receptor AgonistsMahesh M Umapathysivam, Elisa Araldi, Benoit Hastoy, et al.Diabetes Care|December 16, 2020
Processes Underlying Glycemic Deterioration in Type 2 Diabetes: An IMI DIRECT StudyRoberto Bizzotto, Christopher Jennison, Angus G Jones, et al.Pageof 3